Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Lawrence E Heisler
Affiliation
Ontario Institute for Cancer Research
ORCID
Career Start Year
1992
Papers
49
H Index
31
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37874259
Early Cancer Detection in Li-Fraumeni Syndrome with Cell-Free DNA.
Cancer Discov
2024
36610996
A polygenic two-hit hypothesis for prostate cancer.
J Natl Cancer Inst
2023
34737207
Molecular and Pathology Features of Colorectal Tumors and Patient Outcomes Are Associated with <i>Fusobacterium nucleatum</i> and Its Subspecies <i>animalis</i>.
Cancer Epidemiol Biomarkers Prev
2022
34824250
The telomere length landscape of prostate cancer.
Nat Commun
2021
33592074
Prospective observational study and serosurvey of SARS-CoV-2 infection in asymptomatic healthcare workers at a Canadian tertiary care center.
PLoS One
2021
35261998
Detection of the novel SARS-CoV-2 European lineage B.1.177 in Ontario, Canada.
J Clin Virol Plus
2021
32686686
Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival.
Nat Commun
2020
30643250
Molecular landmarks of tumor hypoxia across cancer types.
Nat Genet
2019
31591588
Genome-wide germline correlates of the epigenetic landscape of prostate cancer.
Nat Med
2019
31092540
The Paf1 Complex Broadly Impacts the Transcriptome of Saccharomyces cerevisiae.
Genetics
2019
30889379
The Proteogenomic Landscape of Curable Prostate Cancer.
Cancer Cell
2019
30735634
Widespread and Functional RNA Circularization in Localized Prostate Cancer.
Cell
2019
29681457
The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression.
Cell
2018
29988082
Prediction of acute myeloid leukaemia risk in healthy individuals.
Nature
2018
28067867
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories.
Nat Commun
2017
28939825
Mitochondrial mutations drive prostate cancer aggression.
Nat Commun
2017
28658204
Tracing the origins of relapse in acute myeloid leukaemia to stem cells.
Nature
2017
27851734
Erratum: A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns.
Nature
2017
28068672
Genomic hallmarks of localized, non-indolent prostate cancer.
Nature
2017
27732578
A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns.
Nature
2016
26647970
A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing.
Nat Commun
2015
24723613
Mapping the cellular response to small molecules using chemogenomic fitness signatures.
Science
2014
24944581
A genome scale overexpression screen to reveal drug activity in human cells.
Genome Med
2014
24561123
CHIP-MYTH: a novel interactive proteomics method for the assessment of agonist-dependent interactions of the human β⿿-adrenergic receptor.
Biochem Biophys Res Commun
2014
23109428
Effects of the Paf1 complex and histone modifications on snoRNA 3'-end formation reveal broad and locus-specific regulation.
Mol Cell Biol
2013
23797109
Miniature short hairpin RNA screens to characterize antiproliferative drugs.
G3 (Bethesda)
2013
22928710
Comparative chemogenomics to examine the mechanism of action of dna-targeted platinum-acridine anticancer agents.
ACS Chem Biol
2012
23050238
Functional analysis with a barcoder yeast gene overexpression system.
G3 (Bethesda)
2012
22727066
Identification of yeast genes that confer resistance to chitosan oligosaccharide (COS) using chemogenomics.
BMC Genomics
2012
21572441
Dosage suppression genetic interaction networks enhance functional wiring diagrams of the cell.
Nat Biotechnol
2011
22035796
Compound prioritization methods increase rates of chemical probe discovery in model organisms.
Chem Biol
2011
22102822
Multiple means to the same end: the genetic basis of acquired stress resistance in yeast.
PLoS Genet
2011
21860376
Competitive genomic screens of barcoded yeast libraries.
J Vis Exp
2011
21548937
A comprehensive platform for highly multiplexed mammalian functional genetic screens.
BMC Genomics
2011
20413493
Genotype to phenotype: a complex problem.
Science
2010
20460461
Highly-multiplexed barcode sequencing: an efficient method for parallel analysis of pooled samples.
Nucleic Acids Res
2010
19825181
A comparative analysis of DNA barcode microarray feature size.
BMC Genomics
2009
19622793
Quantitative phenotyping via deep barcode sequencing.
Genome Res
2009
18622398
Yeast Barcoders: a chemogenomic application of a universal donor-strain collection carrying bar-code identifiers.
Nat Methods
2008
19043571
Chemical-genetic profiling of imidazo[1,2-a]pyridines and -pyrimidines reveals target pathways conserved between yeast and human cells.
PLoS Genet
2008
18688276
Off-target effects of psychoactive drugs revealed by genome-wide assays in yeast.
PLoS Genet
2008
17251300
Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T cells.
J Virol
2007
16840529
Genomic DNA functions as a universal external standard in quantitative real-time PCR.
Nucleic Acids Res
2006
15911630
CpG Island microarray probe sequences derived from a physical library are representative of CpG Islands annotated on the human genome.
Nucleic Acids Res
2005
9027364
Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor.
Mol Cell Endocrinol
1997
8585096
In vitro labeling of gonadal steroid hormone receptors in brain tissue sections.
Steroids
1995
7969788
Vasopressin mediates hypoglycemia-induced inhibition of luteinizing hormone secretion in the ovariectomized rhesus monkey.
Neuroendocrinology
1994
8388404
Hypoglycemia-induced inhibition of luteinizing hormone secretion in the rhesus monkey is not mediated by endogenous opioid peptides.
J Clin Endocrinol Metab
1993
1592876
Progesterone inhibits the estrogen-induced gonadotropin surge in the rhesus monkey independent of endogenous opiates.
J Clin Endocrinol Metab
1992
1 - 49 of 49
Column Actions
Search
Recommended Authors
Lina Gao
Oregon National Primate Research Center
Career Start Year
2010
Number of shared co-authors
1
James W MacDonald
University of Washington
Career Start Year
2003
Number of shared co-authors
4
Stefan Bekiranov
University of Virginia
Career Start Year
2000
Number of shared co-authors
2
Chenwei Lin
Clinical Research Division, Fred Hutchinson Cancer Center
Career Start Year
2000
Number of shared co-authors
5
Braden Boone
HudsonAlpha Institute for Biotechnology
Career Start Year
1999
Number of shared co-authors
0
Shawn Levy
HudsonAlpha Institute for Biotechnology
Career Start Year
1999
Number of shared co-authors
0
Kerby Shedden
University of Michigan ann arbor
Career Start Year
1999
Number of shared co-authors
2
Celine Lefebvre
The Scripps Research Institute
Career Start Year
1999
Number of shared co-authors
2
Martin Hirst
University of British Columbia
Career Start Year
1998
Number of shared co-authors
26
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Career Start Year
1997
Number of shared co-authors
3
Edwin Cuppen
Hartwig Medical Foundation
Career Start Year
1997
Number of shared co-authors
19
Agnes Viale
Memorial Sloan Kettering Cancer Center
Career Start Year
1996
Number of shared co-authors
16
Steven J M Jones
University of British Columbia
Career Start Year
1995
Number of shared co-authors
64
Wolfgang Huber
Technische Universitat Munchen
Career Start Year
1995
Number of shared co-authors
17
Anthony P Orth
Genomics Institute of the Novartis Research Foundation
Career Start Year
1995
Number of shared co-authors
0
Jeremy S Caldwell
Sirna Therapeutics a former subsidiary of Merck & Co., Inc.
Career Start Year
1994
Number of shared co-authors
0
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year
1994
Number of shared co-authors
1
Gary Hardiman
Institute for Global Food Security, Queen's University Belfast
Career Start Year
1994
Number of shared co-authors
1
Marco A Marra
University of British Columbia
Career Start Year
1993
Number of shared co-authors
66
Sarah L Anzick
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year
1993
Number of shared co-authors
1
Samuel Aparicio
University of British Columbia
Career Start Year
1993
Number of shared co-authors
25
Sofie R Salama
Genomics Institute, University of California Santa Cruz
Career Start Year
1990
Number of shared co-authors
5
Michael A Newton
University of Wisconsin School of Medicine and Public Health
Career Start Year
1990
Number of shared co-authors
1
Abdel G Elkahloun
National Human Genome Research Institute
Career Start Year
1990
Number of shared co-authors
2
John Quackenbush
Harvard T. H. Chan School of Public Health
Career Start Year
1989
Number of shared co-authors
11
Roderick V Jensen
Virginia Tech
Career Start Year
1985
Number of shared co-authors
3
Ralf Kittler
McDermott Center for Human Growth and Development.
Career Start Year
1984
Number of shared co-authors
2
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year
1982
Number of shared co-authors
4
Michael Snyder
Stanford University
Career Start Year
1981
Number of shared co-authors
16
Richard M Myers
HudsonAlpha Institute for Biotechnology
Career Start Year
1980
Number of shared co-authors
14
row(s) 1 - 30 of 30
Collaborators
Paul C Boutros
University of California los angeles
Co-authored papers
12
Robert G Bristow
University of Toronto
Co-authored papers
10
John D McPherson
Ontario Institute for Cancer Research
Co-authored papers
10
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
9
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers
9
Julie Livingstone
University of California los angeles
Co-authored papers
9
Takafumi N Yamaguchi
University of California los angeles
Co-authored papers
8
Vincent Huang
Ontario Institute for Cancer Research
Co-authored papers
8
Yu-Jia Shiah
Ontario Institute for Cancer Research
Co-authored papers
7
Lee Timms
Ontario Institute for Cancer Research, University Avenue
Co-authored papers
7
Melvin L K Chua
National Cancer Centre Singapore
Co-authored papers
6
Thomas J Hudson
Ontario Institute for Cancer Research
Co-authored papers
6
Shadrielle Melijah G Espiritu
Ontario Institute for Cancer Research
Co-authored papers
5
Marinella Gebbia
University of Toronto
Co-authored papers
5
Natalie S Fox
University of California los angeles
Co-authored papers
5
Fouad Yousif
Ontario Institute for Cancer Research
Co-authored papers
5
Charles Boone
University of Toronto
Co-authored papers
5
Jeremy Johns
Rutgers Robert Wood Johnson Medical School
Co-authored papers
4
Iain M Wallace
Novartis Institutes for BioMedical Research
Co-authored papers
4
Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Co-authored papers
4
Jared T Simpson
Ontario Institute for Cancer Research
Co-authored papers
4
Peter J Campbell
Wellcome Sanger Institute
Co-authored papers
4
Kathleen E Houlahan
University of California los angeles
Co-authored papers
4
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers
4
Dax Torti
Ontario Institute for Cancer Research
Co-authored papers
4
Timothy Beck
Human Longevity Inc.
Co-authored papers
4
Anna Y Lee
Ontario Institute for Cancer Research
Co-authored papers
4
Robert E Denroche
Ontario Institute for Cancer Research
Co-authored papers
4
Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers
4
John E Dick
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
4
1 - 30